CYTOTOXIC AND ANTI-TUMOR EFFECTS OF THE CHEMOTHERAPEUTIC DRUG CYCLOPHOSPHAMIDE IN TUMOR BEARING MICE IS TIME AND DOSE DEPENDENT
Salem, M., Nassef, M., Abdel-Salam, S., Alshorbagy, I., Ata, A. (2014). CYTOTOXIC AND ANTI-TUMOR EFFECTS OF THE CHEMOTHERAPEUTIC DRUG CYCLOPHOSPHAMIDE IN TUMOR BEARING MICE IS TIME AND DOSE DEPENDENT. EKB Journal Management System, 62(62), 131-146. doi: 10.12816/0009340
Mohamed L. Salem; Mohamed N. M. Nassef; Soha G. R. Abdel-Salam; Ibrahim K. Alshorbagy; Asmaa S. Ata. "CYTOTOXIC AND ANTI-TUMOR EFFECTS OF THE CHEMOTHERAPEUTIC DRUG CYCLOPHOSPHAMIDE IN TUMOR BEARING MICE IS TIME AND DOSE DEPENDENT". EKB Journal Management System, 62, 62, 2014, 131-146. doi: 10.12816/0009340
Salem, M., Nassef, M., Abdel-Salam, S., Alshorbagy, I., Ata, A. (2014). 'CYTOTOXIC AND ANTI-TUMOR EFFECTS OF THE CHEMOTHERAPEUTIC DRUG CYCLOPHOSPHAMIDE IN TUMOR BEARING MICE IS TIME AND DOSE DEPENDENT', EKB Journal Management System, 62(62), pp. 131-146. doi: 10.12816/0009340
Salem, M., Nassef, M., Abdel-Salam, S., Alshorbagy, I., Ata, A. CYTOTOXIC AND ANTI-TUMOR EFFECTS OF THE CHEMOTHERAPEUTIC DRUG CYCLOPHOSPHAMIDE IN TUMOR BEARING MICE IS TIME AND DOSE DEPENDENT. EKB Journal Management System, 2014; 62(62): 131-146. doi: 10.12816/0009340

CYTOTOXIC AND ANTI-TUMOR EFFECTS OF THE CHEMOTHERAPEUTIC DRUG CYCLOPHOSPHAMIDE IN TUMOR BEARING MICE IS TIME AND DOSE DEPENDENT

Egyptian Journal of Zoology
Article 6, Volume 62, Issue 62, December 2014, Page 131-146  XML
Document Type: Original Research Papers
DOI: 10.12816/0009340
View on SCiNiTO View on SCiNiTO
Authors
Mohamed L. Salem email 1; Mohamed N. M. Nassef2; Soha G. R. Abdel-Salam2; Ibrahim K. Alshorbagy2; Asmaa S. Ata2
1Zoology Department, Faculty of Science, Tanta University, Tanta, Egypt / Center of Excellence in Cancer Research, Tanta University, Tanta, Egypt
2Zoology Department, Faculty of Science, Tanta University, Tanta, Egypt
Abstract
Cyclophosphamide (CTX) has been used to precondition recipient hosts before adoptive T cell therapy to tumor. The aim of the present study was to analyze the host cellularity changes resulting from different doses and timing of CTX administration. To address this aim, Ehrlich ascites carcinoma (EAC)-bearing mice (5×105cells/mouse) were intraperitoneal injected with 2 or 4 mg/mouse CTX either on day 1 or 7. The results revealed a significant decrease in the number of the tumor cells at 4 mg/mouse CTX on day 1 with an induction of 99% (11.6×106 cells/µl) death of the EAC cells. On day 1 post-EAC cells inoculation, there was a significant increase in the absolute number of splenocytes in EAC-bearing mice at 2 and 4 mg/mouse CTX. The absolute number of leukocytes, lymphocytes and monocytes in EAC-bearing mice non-significantly increased at 2 mg/mouse CTX on day 7 and at 4 mg/mouse CTX on day 1 and 7. Additionally, the absolute number of neutrophils was significantly increased at 2 mg/mouse CTX on day 7 and non-significantly increased at 4 mg/mouse CTX on day 7. The results indicate that: 1) the anti-tumor effect of CTX is a dose- and time-dependent, 2) the use of high dose of chemotherapy is preferable to anti-tumor adoptive cell therapy since it induces higher anti-tumor effects with less lymphopenia.
Keywords
Adoptive cell therapy; Antitumoractivity; CTX; EAC-bearing mice; Leucocytes
Statistics
Article View: 119